1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Vemurafenib
Trade Name:
Zelboraf
Manufacturer/Distributor:
Hoffman-La Roche Ltd.
www.rochecanada.com 1-888-762-4388
Classification:
Protein kinase inhibitor
ATC Class:
L01XE15 - Vemurafenib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2012/02/15
Date Marketed in Canada (yyyy/mm/dd):
2012/03/06
Presentation:
Tablet: 240 mg. DIN: 02380242
Comments:
Indicated as monotherapy for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma. Should only be prescribed and supervised by a qualified physician experienced in the use of anti-cancer agents.
